INBX: Inhibrx Biosciences, Inc. Common Stock Company Profile & Statistics

About

Inhibrx Inc. is a clinical-stage biopharmaceutical company. It focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.

Info & Links

CEO

Mark P. Lappe

Headquarters

11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

Employees

161

Inhibrx Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

165.75M

Enterprise Value

13.15M

Enterprise Value/EBITDA(ttm)

-0.04

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

1.04

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

Profit Margin(ttm)

445177.26%

Return on Equity(ttm)

-113.74%

Return on Invested Capital(ttm)

1222.05%

Return on Assets(ttm)

-80.56%

Income Statement

Revenue(ttm)

200.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

200.00K

EBITDA(ttm)³

-329.16M

Net Income Available to Common(ttm)

1.69B

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

-66.80%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

14.48M

Dividend Yield

0.00%

Float⁴

11.26M

% Held by Insiders

22.20%

% Held by Institutions

82.46%

Balance Sheet

Total Cash(mrq)

152.60M

Total Cash Per Share(mrq)

10.54

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.94%

Quick Ratio(mrq)

4.70%

Book Value Per Share(mrq)

9.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-12.97

Free Cash Flow(ytd)

-197.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

INBX

Inhibrx Biosciences, Inc. Common Stock

Inhibrx Biosciences, Inc. Common Stock Profile